2020 Conference

The 18th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 24–25 September 2020.

The 2020 IOTOD Scientific Committee headed-up the two-day meeting, with international experts invited to speak on topics such as opioid analgesic dependence (OAD), opioid substitution therapy adherance, long-acting buprenorphine formulations, and HIV and HCV. The webcasts from this year’s conference are available to view below.


Polysubstance use: the consequences for opioid substitution therapy

Stephan Walcher

How can we improve adherence and effectiveness of medications for opioid use disorder?

Professor Sir John Strang

Women use drugs too: overcoming the barriers to treatment and care

Gabriele Fischer

Optimising care for PWUDs in the prison setting

Heino Stöver

Tackling the increasing drug problems in Scotland — what else can be done?

Catriona Matheson

Preventing and identifying OAD in patients with chronic pain

Arun Bhaskar

I think my pain patient has OAD: what do I do now?

Duncan Hill, Jeremy Hayllar, Michael Kelleher

An overview of long-acting buprenorphine formulations

Nick Lintzeris

The perspectives from PWUDs, HCPs and public health

Duncan Hill, Catriona Matheson and Mat Southwell

Hepatitis B virus among PWIDs: the forgotten virus?

Professor Ashley Brown

Can we do more for HCV care among PWIDs?

Graham Foster

Unravelling drug-drug interactions of antivirals and OST

Duncan Hill

Complex cases: panel discussion

Graham Foster, Stephan Walcher, Jane Quinlan, Duncan Hill

The IOTOD conference offers a range of exciting and interactive sessions, involving thought-provoking talks and expert-led panel discussions.

Date: 18th and 19th May 2020

Location: Steigenberger Airpot Hotel, Amsterdam


We are currently looking for sponsorship for the IOTOD 2020 conference. If you are interested in sponsoring this event then please get in touch by emailing monica@pcmscientific.com

Full agenda and accreditation information coming soon!


  • Addressing challenges faced during opioid substitution therapy
  • Deconstructing stigma: recognising the needs of drug-using populations
  • Shining a light on opioid analgesic dependence
  • Long-acting buprenorphine formulations: a panoramic view
  • Strategies for improving viral hepatitis care among PWIDs
  • Complex cases: panel discussion

The IOTOD experience


Measuring behavioural changes

2011 marked the year measurement of delegate behavioural changes began. These measurements showed the IOTOD conference elicited measurable significant improvements in physician behaviours over the years, which have been published in the European Journal of CME.


IOTOD’s commitment to change


Professor Catriona Matheson

Professor in Substance Use, University of Stirling

Stirling, UK

Professor Gabriele Fischer

Addictions Clinic Medical Director, Medical University of Vienna

Vienna, Austria

Professor John Marsden

Professor of Addiction Psychology, Kings College London

London, UK

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Dr Jane Quinlan

Oxford University Hospitals Trust

Oxford, UK

Mr Mat Southwell

European Network of People who Use Drugs (EuroNPUD)

Bath, UK

Dr Stephan Walcher

Director, Concept centre for addiction medicine, Munich, Germany

Munich, Germany

Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Dr Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK

Gold Sponsors


Gilead Sciences


Social Media Auto Publish Powered By : XYZScripts.com